Related Experiment Video

Updated: Apr 17, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
10:06

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

1.0K

Respiratory infections: fungal infections

Beth A Choby1, Paul Hunter2

  • 1University of Tennessee College of Medicine, 920 Madison Avenue Suite 700, Memphis, TN 38163, bchoby@uthsc.edu.

FP Essentials
|February 17, 2015
PubMed

Insights

Fungal pneumonia, though less common than bacterial or viral types, can be severe even in healthy individuals. Recent advances improve diagnosis and management, emphasizing history, new tests, and azole antibiotics.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Fungal pneumonia is a less common but potentially lethal cause of pneumonia.
  • Fungal infections can affect both immunocompromised and immunocompetent individuals.
  • Historically, diagnosis and management have faced challenges, leading to delayed treatment.

Purpose of the Study:

  • To highlight recent advances in the diagnosis and management of fungal pneumonia.
  • To emphasize the importance of clinical history in identifying risk factors.
  • To introduce newer diagnostic tools and therapeutic options.

Main Methods:

  • Review of recent literature on fungal pneumonia diagnosis and treatment.
  • Emphasis on detailed patient history, including geographic location and environmental exposures.
  • Discussion of novel diagnostic techniques: galactomannan antigen testing, polymerase chain reaction (PCR), and breath testing.

Main Results:

  • Advances in diagnostic methods offer earlier and more accurate detection of fungal infections.
  • Newer azole antibiotics provide effective treatment options for various fungal pathogens.
  • Recognition that fungal pneumonia can present severely in immunocompetent hosts.

Conclusions:

  • Early and accurate diagnosis of fungal pneumonia is crucial for timely intervention.
  • A combination of thorough patient history and advanced diagnostic tests improves outcomes.
  • Modern antifungal therapies, including newer azoles, are effective in managing these infections.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

11.2K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.3K

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.9K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
45
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K